SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001108205-24-000035
Filing Date
2024-05-14
Accepted
2024-05-14 16:04:35
Documents
28
Period of Report
2024-05-14
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cris-20240514.htm   iXBRL 8-K 51669
2 EX-99.1 curis-takeaimleukemiadatar.htm EX-99.1 24216
3 EX-99.2 a2024-05corporatepresent.htm EX-99.2 33512
7 a2024-05corporatepresent001.jpg GRAPHIC 560554
8 a2024-05corporatepresent002.jpg GRAPHIC 365437
9 a2024-05corporatepresent003.jpg GRAPHIC 373153
10 a2024-05corporatepresent004.jpg GRAPHIC 378845
11 a2024-05corporatepresent005.jpg GRAPHIC 343438
12 a2024-05corporatepresent006.jpg GRAPHIC 341022
13 a2024-05corporatepresent007.jpg GRAPHIC 420712
14 a2024-05corporatepresent008.jpg GRAPHIC 326474
15 a2024-05corporatepresent009.jpg GRAPHIC 317152
16 a2024-05corporatepresent010.jpg GRAPHIC 352839
17 a2024-05corporatepresent011.jpg GRAPHIC 314977
18 a2024-05corporatepresent012.jpg GRAPHIC 67997
19 image_0a.jpg GRAPHIC 13933
  Complete submission text file 0001108205-24-000035.txt   6014424

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cris-20240514.xsd EX-101.SCH 1908
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cris-20240514_lab.xml EX-101.LAB 22548
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cris-20240514_pre.xml EX-101.PRE 13054
31 EXTRACTED XBRL INSTANCE DOCUMENT cris-20240514_htm.xml XML 2821
Mailing Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421
Business Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421 617-503-6500
CURIS INC (Filer) CIK: 0001108205 (see all company filings)

IRS No.: 043505116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30347 | Film No.: 24944176
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)